726 related articles for article (PubMed ID: 25114856)
1. Biological subtypes of breast cancer: Prognostic and therapeutic implications.
Yersal O; Barutca S
World J Clin Oncol; 2014 Aug; 5(3):412-24. PubMed ID: 25114856
[TBL] [Abstract][Full Text] [Related]
2. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
3. A novel morphologic-molecular recurrence predictive model refines traditional prognostic tools for invasive breast carcinoma.
Ni YB; Tsang JY; Chan SK; Tse GM
Ann Surg Oncol; 2014 Sep; 21(9):2928-33. PubMed ID: 24743910
[TBL] [Abstract][Full Text] [Related]
4. Discerning Clinical Responses in Breast Cancer Based On Molecular Signatures.
Coleman WB; Anders CK
Am J Pathol; 2017 Oct; 187(10):2199-2207. PubMed ID: 28822803
[TBL] [Abstract][Full Text] [Related]
5. Molecular classification of infiltrating breast cancer: toward personalized therapy.
Trop I; LeBlanc SM; David J; Lalonde L; Tran-Thanh D; Labelle M; El Khoury MM
Radiographics; 2014; 34(5):1178-95. PubMed ID: 25208275
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401
[TBL] [Abstract][Full Text] [Related]
7. Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value.
Marisa L; de Reyniès A; Duval A; Selves J; Gaub MP; Vescovo L; Etienne-Grimaldi MC; Schiappa R; Guenot D; Ayadi M; Kirzin S; Chazal M; Fléjou JF; Benchimol D; Berger A; Lagarde A; Pencreach E; Piard F; Elias D; Parc Y; Olschwang S; Milano G; Laurent-Puig P; Boige V
PLoS Med; 2013; 10(5):e1001453. PubMed ID: 23700391
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological classification and traditional prognostic indicators of breast cancer.
Li J; Chen Z; Su K; Zeng J
Int J Clin Exp Pathol; 2015; 8(7):8500-5. PubMed ID: 26339424
[TBL] [Abstract][Full Text] [Related]
9. Prognostic applications of gene expression signatures in breast cancer.
Normanno N; De Luca A; Carotenuto P; Lamura L; Oliva I; D'Alessio A
Oncology; 2009; 77 Suppl 1():2-8. PubMed ID: 20130425
[TBL] [Abstract][Full Text] [Related]
10. Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics.
Jönsson G; Staaf J; Vallon-Christersson J; Ringnér M; Holm K; Hegardt C; Gunnarsson H; Fagerholm R; Strand C; Agnarsson BA; Kilpivaara O; Luts L; Heikkilä P; Aittomäki K; Blomqvist C; Loman N; Malmström P; Olsson H; Johannsson OT; Arason A; Nevanlinna H; Barkardottir RB; Borg A
Breast Cancer Res; 2010; 12(3):R42. PubMed ID: 20576095
[TBL] [Abstract][Full Text] [Related]
11. An update on the pathological classification of breast cancer.
Rakha EA; Tse GM; Quinn CM
Histopathology; 2023 Jan; 82(1):5-16. PubMed ID: 36482272
[TBL] [Abstract][Full Text] [Related]
12. Exploring novel targets of basal-like breast carcinoma by comparative gene profiling and mechanism analysis.
Wu YM; Hu W; Wang Y; Wang N; Gao L; Chen ZZ; Zheng WQ
Breast Cancer Res Treat; 2013 Aug; 141(1):23-32. PubMed ID: 23933801
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer prognostic classification in the molecular era: the role of histological grade.
Rakha EA; Reis-Filho JS; Baehner F; Dabbs DJ; Decker T; Eusebi V; Fox SB; Ichihara S; Jacquemier J; Lakhani SR; Palacios J; Richardson AL; Schnitt SJ; Schmitt FC; Tan PH; Tse GM; Badve S; Ellis IO
Breast Cancer Res; 2010; 12(4):207. PubMed ID: 20804570
[TBL] [Abstract][Full Text] [Related]
14. Prognostic immune-related gene models for breast cancer: a pooled analysis.
Zhao J; Wang Y; Lao Z; Liang S; Hou J; Yu Y; Yao H; You N; Chen K
Onco Targets Ther; 2017; 10():4423-4433. PubMed ID: 28979134
[TBL] [Abstract][Full Text] [Related]
15. Biological subtypes of breast cancer: current concepts and implications for recurrence patterns.
Cadoo KA; Fornier MN; Morris PG
Q J Nucl Med Mol Imaging; 2013 Dec; 57(4):312-21. PubMed ID: 24322788
[TBL] [Abstract][Full Text] [Related]
16. Molecular classification and molecular forecasting of breast cancer: ready for clinical application?
Brenton JD; Carey LA; Ahmed AA; Caldas C
J Clin Oncol; 2005 Oct; 23(29):7350-60. PubMed ID: 16145060
[TBL] [Abstract][Full Text] [Related]
17. Building prognostic models for breast cancer patients using clinical variables and hundreds of gene expression signatures.
Fan C; Prat A; Parker JS; Liu Y; Carey LA; Troester MA; Perou CM
BMC Med Genomics; 2011 Jan; 4():3. PubMed ID: 21214954
[TBL] [Abstract][Full Text] [Related]
18. Predictive and prognostic value of FDG-PET/CT imaging and different response evaluation criteria after primary systemic therapy of breast cancer.
Tőkés T; Kajáry K; Szentmártoni G; Lengyel Z; Györke T; Torgyík L; Somlai K; Tőkés AM; Kulka J; Dank M
Breast Cancer; 2017 Jan; 24(1):137-146. PubMed ID: 26979062
[TBL] [Abstract][Full Text] [Related]
19. lncRNA Gene Signatures for Prediction of Breast Cancer Intrinsic Subtypes and Prognosis.
Zhang S; Wang J; Ghoshal T; Wilkins D; Mo YY; Chen Y; Zhou Y
Genes (Basel); 2018 Jan; 9(2):. PubMed ID: 29373522
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]